BRIEF-Northwest Biotherapeutics down 17.4 percent premarket; plans common stock offering

NEW YORK, Nov 20 (Reuters) - Northwest Biotherapeutics Inc (NWBO) : * Down 17.4 percent to $5.50 in premarket; plans common stock offering


(c) Reuters 2013. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.